News
Moderna (Nasdaq: MRNA) today reported financial results and provided business updates for the first quarter of 2025, which ...
Shares in US drug major Eli Lilly were a hefty 8% down early Thursday after the Indianapolis firm announced its first quarter financial results and latest guidance for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback